State Ledger
Company profile

Syndax Pharmaceuticals Inc CIK 1395937

Ticker
SNDX (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
New York, NY 10017
Fiscal year end
2025 (FY)
Market Data
Close
$16.54
Change
-$0.45
Change %
-2.65%
Volume
76,151

SNDX · trading date Oct 12, 2026 · previous close $16.99 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$172.35M
Net income
-$285.42M
Total assets
$529.71M
Total liabilities
$465.08M
Stockholders' equity
$64.63M
Cash & equivalents
$134.93M
Operating income
-$273.08M
Operating cash flow
-$322.98M
Capital expenditures
$187.0K

Fiscal year 2025, via 10-K filed 2026-02-26. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
-158.4%
Net margin
-165.6%
Free cash flow
-$323.17M
Free cash flow margin
-187.5%
Liabilities / assets
87.8%
Equity / assets
12.2%
CapEx / revenue
0.1%
Operating cash flow / net income
1.13×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $172.35M -$285.42M $529.71M $465.08M $64.63M
2024 $23.68M -$318.76M $724.82M $436.69M $288.12M
2023 $0 -$209.36M $612.88M $58.68M $554.20M
2022 $0 -$149.34M $497.24M $29.79M $467.45M
2021 $139.71M $24.93M $449.66M $41.29M $408.37M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form SCHEDULE 13G
2026-08-07
Financials filed via
Form 10-K
filed 2026-02-26

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
New York, NY 10017
730 THIRD AVENUE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:43 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to New York — Public Companies